Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia
Clinical trial NCT02828774 · UNKNOWN
Trial details
- NCT number
- NCT02828774
- Sponsor
- Assuta Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-08-01
- Primary completion
- 2019-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.